| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH2 MYH3 MYH4 DNAL4 MYH6 MYH7 MYH8 KIF3B MYH13 MYH7B DNAH17 | 4.59e-16 | 118 | 56 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.36e-16 | 38 | 56 | 9 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 DNAL4 MYH6 MYH7 MYH8 KIF3B MYH13 MYH7B DNAH17 YME1L1 | 1.09e-08 | 614 | 56 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 1.29e-08 | 227 | 56 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.44e-08 | 230 | 56 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CLIP4 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 KIF3B MYH13 RTCB CENPF CETN1 MYH7B TMSB4X STMND1 | 3.29e-08 | 1099 | 56 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | 7.61e-07 | 479 | 56 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.00e-03 | 70 | 56 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.43e-03 | 441 | 56 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.75e-03 | 85 | 56 | 3 | GO:0017018 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 3.55e-03 | 109 | 56 | 3 | GO:0004722 | |
| GeneOntologyMolecularFunction | protein sequestering activity | 4.09e-03 | 34 | 56 | 2 | GO:0140311 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.33e-12 | 15 | 55 | 6 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 4.91e-12 | 18 | 55 | 6 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 4.51e-08 | 127 | 55 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CLIP4 FSIP2 CCP110 DNAL4 FLOT2 KIF3B CETN1 DNAH17 CFAP45 FYCO1 STMND1 CKAP2 DNAI3 CCDC38 ADCY3 | 6.98e-08 | 1058 | 55 | 15 | GO:0007017 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.62e-07 | 153 | 55 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | FSIP2 DNAL4 FLOT2 KIF3B DNAH17 CFAP45 FYCO1 DNAI3 CCDC38 ADCY3 | 6.20e-07 | 493 | 55 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | muscle contraction | 1.02e-06 | 400 | 55 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.30e-05 | 547 | 55 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.98e-05 | 210 | 55 | 6 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 2.27e-05 | 215 | 55 | 6 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 2.27e-05 | 215 | 55 | 6 | GO:0060285 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 2.39e-05 | 912 | 55 | 11 | GO:0030029 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CLIP4 CYP1B1 MYH3 MYH6 MYH7 TMSB4X STMND1 PFDN4 CKAP2 DNAI3 RUFY3 | 3.71e-05 | 957 | 55 | 11 | GO:0097435 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 5.96e-05 | 512 | 55 | 8 | GO:0009150 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 6.14e-05 | 257 | 55 | 6 | GO:0046034 | |
| GeneOntologyBiologicalProcess | cilium movement | 6.68e-05 | 261 | 55 | 6 | GO:0003341 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 7.89e-05 | 533 | 55 | 8 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 8.64e-05 | 540 | 55 | 8 | GO:0019693 | |
| GeneOntologyBiologicalProcess | plus-end-directed vesicle transport along microtubule | 1.04e-04 | 6 | 55 | 2 | GO:0072383 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 1.04e-04 | 283 | 55 | 6 | GO:0009205 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 1.10e-04 | 720 | 55 | 9 | GO:0000226 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 1.19e-04 | 290 | 55 | 6 | GO:0009199 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 1.22e-04 | 291 | 55 | 6 | GO:0009144 | |
| GeneOntologyBiologicalProcess | plus-end-directed organelle transport along microtubule | 1.45e-04 | 7 | 55 | 2 | GO:0072386 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 1.63e-04 | 307 | 55 | 6 | GO:0009141 | |
| GeneOntologyBiologicalProcess | organelle assembly | FSIP2 CCP110 MYH3 MYH6 MYH7 KIF3B CENPF CETN1 DNAH17 DNAI3 CCDC38 | 1.75e-04 | 1138 | 55 | 11 | GO:0070925 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 2.21e-04 | 619 | 55 | 8 | GO:0006163 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 2.57e-04 | 475 | 55 | 7 | GO:0140694 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.79e-04 | 217 | 55 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | formation of translation preinitiation complex | 3.10e-04 | 10 | 55 | 2 | GO:0001731 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 3.13e-04 | 652 | 55 | 8 | GO:0072521 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 3.61e-04 | 52 | 55 | 3 | GO:0003009 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 4.31e-04 | 684 | 55 | 8 | GO:0009117 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 4.35e-04 | 685 | 55 | 8 | GO:0030031 | |
| GeneOntologyBiologicalProcess | anterograde dendritic transport | 4.53e-04 | 12 | 55 | 2 | GO:0098937 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 4.61e-04 | 691 | 55 | 8 | GO:0006753 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 5.25e-04 | 59 | 55 | 3 | GO:0045214 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 5.63e-04 | 253 | 55 | 5 | GO:0099111 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 7.96e-04 | 156 | 55 | 4 | GO:0010927 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 7.96e-04 | 156 | 55 | 4 | GO:0032989 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 8.30e-04 | 69 | 55 | 3 | GO:0050881 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 9.14e-04 | 767 | 55 | 8 | GO:0055086 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 9.78e-04 | 73 | 55 | 3 | GO:0050879 | |
| GeneOntologyBiologicalProcess | adult heart development | 1.04e-03 | 18 | 55 | 2 | GO:0007512 | |
| GeneOntologyBiologicalProcess | cilium assembly | 1.14e-03 | 444 | 55 | 6 | GO:0060271 | |
| GeneOntologyBiologicalProcess | dendritic transport | 1.16e-03 | 19 | 55 | 2 | GO:0098935 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 1.53e-03 | 186 | 55 | 4 | GO:0030317 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.57e-03 | 86 | 55 | 3 | GO:0030239 | |
| GeneOntologyBiologicalProcess | cilium organization | 1.63e-03 | 476 | 55 | 6 | GO:0044782 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.73e-03 | 89 | 55 | 3 | GO:0055002 | |
| GeneOntologyBiologicalProcess | sperm motility | 1.75e-03 | 193 | 55 | 4 | GO:0097722 | |
| GeneOntologyBiologicalProcess | response to activity | 1.79e-03 | 90 | 55 | 3 | GO:0014823 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 1.88e-03 | 197 | 55 | 4 | GO:0010970 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.88e-03 | 197 | 55 | 4 | GO:1902904 | |
| GeneOntologyCellularComponent | myosin filament | 7.15e-18 | 25 | 56 | 9 | GO:0032982 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.99e-17 | 16 | 56 | 8 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin II complex | 2.40e-17 | 28 | 56 | 9 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 4.10e-14 | 59 | 56 | 9 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | 4.29e-08 | 273 | 56 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.20e-08 | 290 | 56 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | supramolecular fiber | CLIP4 MYH1 MYH2 MYH3 MYH4 DNAL4 MYH6 MYH7 MYH8 KIF3B MYH13 MYH7B DNAH17 CFAP45 CKAP2 | 3.10e-07 | 1179 | 56 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CLIP4 MYH1 MYH2 MYH3 MYH4 DNAL4 MYH6 MYH7 MYH8 KIF3B MYH13 MYH7B DNAH17 CFAP45 CKAP2 | 3.38e-07 | 1187 | 56 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | cilium | FSIP2 CCP110 DNAL4 KIF3B CENPF CETN1 DNAH17 CFAP45 TSGA10 DLD DNAI3 CCDC38 ADCY3 | 5.29e-07 | 898 | 56 | 13 | GO:0005929 |
| GeneOntologyCellularComponent | actin cytoskeleton | 2.66e-06 | 576 | 56 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | sarcomere | 4.41e-06 | 249 | 56 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | microtubule organizing center | TCEA2 CCP110 KIF3B CENPF CDKL2 RBBP6 CETN1 TSGA10 CKAP2 CCDC38 | 1.45e-04 | 919 | 56 | 10 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | 1.91e-04 | 770 | 56 | 9 | GO:0005813 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.99e-04 | 317 | 56 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | motile cilium | 3.65e-04 | 355 | 56 | 6 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.93e-04 | 360 | 56 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | dynein complex | 4.10e-04 | 54 | 56 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 4.37e-04 | 238 | 56 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | microtubule associated complex | 9.12e-04 | 161 | 56 | 4 | GO:0005875 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.03e-03 | 25 | 56 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | axoneme | 2.29e-03 | 207 | 56 | 4 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.33e-03 | 208 | 56 | 4 | GO:0097014 | |
| GeneOntologyCellularComponent | sperm flagellum | 2.59e-03 | 214 | 56 | 4 | GO:0036126 | |
| GeneOntologyCellularComponent | microtubule | 2.95e-03 | 533 | 56 | 6 | GO:0005874 | |
| GeneOntologyCellularComponent | acrosomal membrane | 4.66e-03 | 38 | 56 | 2 | GO:0002080 | |
| GeneOntologyCellularComponent | dendrite cytoplasm | 4.90e-03 | 39 | 56 | 2 | GO:0032839 | |
| Domain | Myosin_N | 2.39e-20 | 15 | 52 | 9 | PF02736 | |
| Domain | Myosin_N | 2.39e-20 | 15 | 52 | 9 | IPR004009 | |
| Domain | Myosin_tail_1 | 2.31e-19 | 18 | 52 | 9 | PF01576 | |
| Domain | Myosin_tail | 2.31e-19 | 18 | 52 | 9 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.38e-19 | 19 | 52 | 9 | IPR027401 | |
| Domain | - | 4.38e-19 | 19 | 52 | 9 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 7.42e-16 | 38 | 52 | 9 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.42e-16 | 38 | 52 | 9 | PS51456 | |
| Domain | Myosin_head | 7.42e-16 | 38 | 52 | 9 | PF00063 | |
| Domain | MYSc | 7.42e-16 | 38 | 52 | 9 | SM00242 | |
| Domain | IQ | 1.09e-12 | 81 | 52 | 9 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.89e-12 | 90 | 52 | 9 | IPR000048 | |
| Domain | IQ | 3.91e-12 | 93 | 52 | 9 | PS50096 | |
| Domain | IQ | 9.89e-10 | 71 | 52 | 7 | PF00612 | |
| Domain | P-loop_NTPase | 1.73e-05 | 848 | 52 | 11 | IPR027417 | |
| Domain | GRIP_dom | 4.93e-04 | 12 | 52 | 2 | IPR000237 | |
| Domain | GRIP | 4.93e-04 | 12 | 52 | 2 | PS50913 | |
| Domain | RUN | 1.26e-03 | 19 | 52 | 2 | PS50826 | |
| Domain | RUN | 1.26e-03 | 19 | 52 | 2 | PF02759 | |
| Domain | Run_dom | 1.26e-03 | 19 | 52 | 2 | IPR004012 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.33e-13 | 70 | 41 | 9 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.14e-10 | 132 | 41 | 9 | M11355 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.40e-04 | 35 | 41 | 3 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.53e-04 | 36 | 41 | 3 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.79e-04 | 38 | 41 | 3 | M39549 | |
| Pubmed | 1.90e-20 | 7 | 56 | 7 | 35210422 | ||
| Pubmed | 1.90e-20 | 7 | 56 | 7 | 16819597 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.32e-17 | 6 | 56 | 6 | 10077619 | |
| Pubmed | 1.32e-17 | 6 | 56 | 6 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.32e-17 | 6 | 56 | 6 | 10588881 | |
| Pubmed | 3.69e-16 | 8 | 56 | 6 | 3864153 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 9.01e-15 | 5 | 56 | 5 | 3829126 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 6196357 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 9.01e-15 | 5 | 56 | 5 | 12919077 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.25e-14 | 13 | 56 | 6 | 8404542 | |
| Pubmed | 3.93e-14 | 14 | 56 | 6 | 27184118 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.05e-13 | 16 | 56 | 6 | 19922871 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.89e-13 | 7 | 56 | 5 | 29758057 | |
| Pubmed | 9.67e-13 | 22 | 56 | 6 | 24301466 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 4.13e-12 | 11 | 56 | 5 | 16024798 | |
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 1985022 | ||
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 10388558 | ||
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 20357587 | ||
| Pubmed | 9.43e-12 | 31 | 56 | 6 | 21985497 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.42e-11 | 33 | 56 | 6 | 32094117 | |
| Pubmed | 1.78e-11 | 14 | 56 | 5 | 24938781 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 2.67e-11 | 15 | 56 | 5 | 24852826 | |
| Pubmed | 5.49e-11 | 17 | 56 | 5 | 16124007 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 1.18e-10 | 46 | 56 | 6 | 28827394 | |
| Pubmed | 4.20e-10 | 8 | 56 | 4 | 26993635 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 4.20e-10 | 8 | 56 | 4 | 14667415 | |
| Pubmed | 5.02e-10 | 58 | 56 | 6 | 21884692 | ||
| Pubmed | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 BBX MYH13 CENPF MYH7B MCTS1 CFAP45 HNRNPM DLD TMSB4X | 6.09e-10 | 1442 | 56 | 16 | 35575683 | |
| Pubmed | 7.55e-10 | 9 | 56 | 4 | 31960486 | ||
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 1.26e-09 | 10 | 56 | 4 | 2211821 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.26e-09 | 10 | 56 | 4 | 8950513 | |
| Pubmed | 1.97e-09 | 11 | 56 | 4 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.97e-09 | 11 | 56 | 4 | 29168801 | |
| Pubmed | 1.97e-09 | 11 | 56 | 4 | 8136524 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.95e-09 | 3 | 56 | 3 | 26059207 | |
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 3.95e-09 | 3 | 56 | 3 | 1939265 | |
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 3.95e-09 | 3 | 56 | 3 | 1371481 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 3.95e-09 | 3 | 56 | 3 | 1694848 | |
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 3.95e-09 | 3 | 56 | 3 | 1691980 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21470888 | ||
| Pubmed | 4.26e-09 | 13 | 56 | 4 | 8948582 | ||
| Pubmed | 4.98e-09 | 39 | 56 | 5 | 38690566 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 MYH7B HNRNPM YME1L1 | 5.92e-09 | 647 | 56 | 11 | 26618866 |
| Pubmed | 5.96e-09 | 14 | 56 | 4 | 38327785 | ||
| Pubmed | 5.96e-09 | 14 | 56 | 4 | 33742095 | ||
| Pubmed | 1.08e-08 | 16 | 56 | 4 | 22090424 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.41e-08 | 17 | 56 | 4 | 22351927 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.58e-08 | 4 | 56 | 3 | 11029314 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 19948655 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 11023856 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.58e-08 | 4 | 56 | 3 | 18417546 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 3.94e-08 | 5 | 56 | 3 | 30737693 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 3.94e-08 | 5 | 56 | 3 | 2277065 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 6879174 | ||
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 3.94e-08 | 5 | 56 | 3 | 17584907 | |
| Pubmed | 4.31e-08 | 22 | 56 | 4 | 37468485 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 28381556 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 7.88e-08 | 6 | 56 | 3 | 17559643 | |
| Pubmed | The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. | 1.38e-07 | 7 | 56 | 3 | 26586200 | |
| Pubmed | 1.84e-07 | 31 | 56 | 4 | 30081710 | ||
| Pubmed | 2.10e-07 | 32 | 56 | 4 | 33732701 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 36200826 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 33667029 | ||
| Pubmed | Muscle-specific gene expression during myogenesis in the mouse. | 3.30e-07 | 9 | 56 | 3 | 7787235 | |
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 19506036 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 6.46e-07 | 11 | 56 | 3 | 38303699 | |
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 30962377 | ||
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 26644518 | ||
| Pubmed | The FgfrL1 receptor is required for development of slow muscle fibers. | 6.46e-07 | 11 | 56 | 3 | 25172430 | |
| Pubmed | 8.61e-07 | 12 | 56 | 3 | 8424456 | ||
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 8.61e-07 | 12 | 56 | 3 | 28600496 | |
| Pubmed | 1.12e-06 | 13 | 56 | 3 | 24876128 | ||
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 1.12e-06 | 13 | 56 | 3 | 7797078 | |
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 1.12e-06 | 13 | 56 | 3 | 10694423 | |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 1.31e-06 | 50 | 56 | 4 | 27597886 | |
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 21071677 | ||
| Pubmed | 1.77e-06 | 15 | 56 | 3 | 28737171 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 16494860 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 29719249 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11150240 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 24224850 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 2.55e-06 | 2 | 56 | 2 | 22337492 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 17575272 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21526716 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16088376 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18480046 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1776652 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9884344 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 2.55e-06 | 2 | 56 | 2 | 9585413 | |
| Pubmed | Murine pulmonary myocardium: developmental analysis of cardiac gene expression. | 2.55e-06 | 2 | 56 | 2 | 7919499 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12750067 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 35759444 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23111184 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9541509 | ||
| Pubmed | Characterization of diverse forms of myosin heavy chain expressed in adult human skeletal muscle. | 2.55e-06 | 2 | 56 | 2 | 2421254 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23580644 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 34384224 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21102503 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 2726733 | ||
| Interaction | RSPH6A interactions | 4.42e-10 | 34 | 56 | 6 | int:RSPH6A | |
| Interaction | PRKAG2 interactions | 7.38e-10 | 68 | 56 | 7 | int:PRKAG2 | |
| Interaction | ASAH2 interactions | 7.99e-10 | 6 | 56 | 4 | int:ASAH2 | |
| Interaction | MYH6 interactions | 7.37e-09 | 94 | 56 | 7 | int:MYH6 | |
| Interaction | STK4 interactions | 1.30e-08 | 159 | 56 | 8 | int:STK4 | |
| Interaction | ACTN2 interactions | 2.29e-08 | 171 | 56 | 8 | int:ACTN2 | |
| Interaction | TSPAN33 interactions | 2.54e-08 | 65 | 56 | 6 | int:TSPAN33 | |
| Interaction | CDK3 interactions | 2.84e-08 | 114 | 56 | 7 | int:CDK3 | |
| Interaction | STK3 interactions | 3.57e-08 | 181 | 56 | 8 | int:STK3 | |
| Interaction | TMEM260 interactions | 3.75e-08 | 13 | 56 | 4 | int:TMEM260 | |
| Interaction | LATS1 interactions | 3.22e-07 | 440 | 56 | 10 | int:LATS1 | |
| Interaction | MYH3 interactions | 3.25e-07 | 52 | 56 | 5 | int:MYH3 | |
| Interaction | MYH8 interactions | 3.25e-07 | 52 | 56 | 5 | int:MYH8 | |
| Interaction | ABTB2 interactions | 3.62e-07 | 101 | 56 | 6 | int:ABTB2 | |
| Interaction | TPM1 interactions | 6.25e-07 | 263 | 56 | 8 | int:TPM1 | |
| Interaction | LZTR1 interactions | 6.32e-07 | 111 | 56 | 6 | int:LZTR1 | |
| Interaction | SBDS interactions | 6.71e-07 | 181 | 56 | 7 | int:SBDS | |
| Interaction | SLC39A3 interactions | 1.46e-06 | 70 | 56 | 5 | int:SLC39A3 | |
| Interaction | BCAP31 interactions | 2.59e-06 | 554 | 56 | 10 | int:BCAP31 | |
| Interaction | KRT40 interactions | 2.83e-06 | 434 | 56 | 9 | int:KRT40 | |
| Interaction | ZSCAN5A interactions | 3.68e-06 | 38 | 56 | 4 | int:ZSCAN5A | |
| Interaction | AURKC interactions | 6.09e-06 | 43 | 56 | 4 | int:AURKC | |
| Interaction | LIMS1 interactions | 7.70e-06 | 98 | 56 | 5 | int:LIMS1 | |
| Interaction | HSPB8 interactions | 8.07e-06 | 172 | 56 | 6 | int:HSPB8 | |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 FLOT2 MYH7 MYH8 GTF2I BBX RTCB CENPF HNRNPM PFDN4 GOLGA4 | 8.09e-06 | 1108 | 56 | 13 | int:HDAC1 |
| Interaction | HIF1A interactions | 2.79e-05 | 441 | 56 | 8 | int:HIF1A | |
| Interaction | MYH4 interactions | 5.05e-05 | 73 | 56 | 4 | int:MYH4 | |
| Interaction | CCDC69 interactions | 7.82e-05 | 30 | 56 | 3 | int:CCDC69 | |
| Interaction | TLE3 interactions | 7.86e-05 | 376 | 56 | 7 | int:TLE3 | |
| Interaction | LACTB2 interactions | 7.96e-05 | 82 | 56 | 4 | int:LACTB2 | |
| Interaction | FKBP6 interactions | 9.58e-05 | 86 | 56 | 4 | int:FKBP6 | |
| Interaction | KXD1 interactions | 1.09e-04 | 170 | 56 | 5 | int:KXD1 | |
| Interaction | LHPP interactions | 1.48e-04 | 37 | 56 | 3 | int:LHPP | |
| Interaction | CFTR interactions | MYH1 MYH2 MYH3 MYH4 FLOT2 MYH6 MYH7 MYH8 GTF2I MYH13 MYH7B HNRNPM YME1L1 | 1.64e-04 | 1480 | 56 | 13 | int:CFTR |
| Interaction | MYH7 interactions | 1.79e-04 | 101 | 56 | 4 | int:MYH7 | |
| Interaction | SIX1 interactions | 3.42e-04 | 49 | 56 | 3 | int:SIX1 | |
| Interaction | METTL26 interactions | 4.10e-04 | 11 | 56 | 2 | int:METTL26 | |
| Interaction | TNNI1 interactions | 4.56e-04 | 54 | 56 | 3 | int:TNNI1 | |
| Interaction | MECOM interactions | 4.63e-04 | 358 | 56 | 6 | int:MECOM | |
| Interaction | CFAP141 interactions | 4.81e-04 | 55 | 56 | 3 | int:CFAP141 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 2.20e-07 | 346 | 56 | 7 | chr17p13 | |
| Cytoband | 17p13.1 | 3.54e-07 | 118 | 56 | 5 | 17p13.1 | |
| Cytoband | 16p12.2 | 9.47e-04 | 37 | 56 | 2 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 1.24e-03 | 172 | 56 | 3 | chr16p12 | |
| Cytoband | 14q12 | 2.08e-03 | 55 | 56 | 2 | 14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q11 | 3.50e-03 | 248 | 56 | 3 | chr20q11 | |
| GeneFamily | Myosin heavy chains | 4.59e-22 | 15 | 34 | 9 | 1098 | |
| GeneFamily | Dyneins, axonemal | 4.59e-04 | 17 | 34 | 2 | 536 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.54e-03 | 31 | 34 | 2 | 81 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 8.82e-08 | 20 | 56 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.09e-07 | 21 | 56 | 4 | MM1102 | |
| Coexpression | HALLMARK_MYOGENESIS | 4.33e-06 | 200 | 56 | 6 | M5909 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN | 4.33e-06 | 200 | 56 | 6 | M5582 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.37e-05 | 610 | 56 | 8 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 4.62e-05 | 615 | 56 | 8 | M8673 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 5.24e-05 | 189 | 56 | 5 | M8275 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 6.81e-05 | 650 | 56 | 8 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 7.50e-05 | 659 | 56 | 8 | MM1040 | |
| Coexpression | LINSLEY_MIR16_TARGETS | 7.88e-05 | 206 | 56 | 5 | M2284 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 1.49e-04 | 48 | 56 | 3 | M16123 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 1.65e-04 | 946 | 56 | 9 | M39169 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.59e-08 | 77 | 56 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 62 | 56 | 4 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 62 | 56 | 4 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 62 | 56 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 62 | 56 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-06 | 65 | 56 | 4 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-06 | 65 | 56 | 4 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-06 | 157 | 56 | 5 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 164 | 56 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 176 | 56 | 5 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-06 | 178 | 56 | 5 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-06 | 179 | 56 | 5 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-06 | 179 | 56 | 5 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.31e-06 | 182 | 56 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.31e-06 | 182 | 56 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.59e-06 | 185 | 56 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-06 | 186 | 56 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-06 | 188 | 56 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 197 | 56 | 5 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.12e-06 | 199 | 56 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.25e-06 | 200 | 56 | 5 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 113 | 56 | 4 | 6f270b7e59c18243e876311df721e948ce21e850 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-05 | 125 | 56 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-05 | 127 | 56 | 4 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.25e-05 | 144 | 56 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.52e-05 | 147 | 56 | 4 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 160 | 56 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 166 | 56 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-05 | 167 | 56 | 4 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.79e-05 | 167 | 56 | 4 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.06e-05 | 169 | 56 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.20e-05 | 170 | 56 | 4 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.49e-05 | 172 | 56 | 4 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 173 | 56 | 4 | a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 173 | 56 | 4 | e3e3a67a5a93ef4475224a256d45ae24526383cc | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.88e-05 | 63 | 56 | 3 | 55f11bb2970a8159166e71af34a0446ecee594e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 56 | 4 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 56 | 4 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 56 | 4 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 8.25e-05 | 183 | 56 | 4 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.96e-05 | 187 | 56 | 4 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.96e-05 | 187 | 56 | 4 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 188 | 56 | 4 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.15e-05 | 188 | 56 | 4 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 188 | 56 | 4 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.53e-05 | 190 | 56 | 4 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.53e-05 | 190 | 56 | 4 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.73e-05 | 191 | 56 | 4 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.01e-04 | 193 | 56 | 4 | 42775588e788c330aade07e54b208f1c2eea3ab3 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.03e-04 | 194 | 56 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 1.07e-04 | 196 | 56 | 4 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | (7)_MNP-(7)_DC_2|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.10e-04 | 197 | 56 | 4 | 795e607fb4c102940344b2f4ea7c16e62fd973d3 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.12e-04 | 198 | 56 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.12e-04 | 198 | 56 | 4 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 1.12e-04 | 198 | 56 | 4 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 199 | 56 | 4 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 199 | 56 | 4 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.14e-04 | 199 | 56 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 199 | 56 | 4 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | distal-1-Epithelial-Ciliated|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 4120e4a2bc05adebe1e1e9670ed7ea55142eb83d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 199 | 56 | 4 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | Int-URO-Myeloid-cDC2|Int-URO / Disease, Lineage and Cell Type | 1.14e-04 | 199 | 56 | 4 | 7bbeda66f522b803f85be65d1a81555e12585efc | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 1.16e-04 | 200 | 56 | 4 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 200 | 56 | 4 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-04 | 200 | 56 | 4 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-04 | 200 | 56 | 4 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.16e-04 | 200 | 56 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.16e-04 | 200 | 56 | 4 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Sepsis-Int-URO-Myeloid-cDC2|Int-URO / Disease, condition lineage and cell class | 1.16e-04 | 200 | 56 | 4 | dd8ac355b3b0394fda005789f9f2ff6560a02dac | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.16e-04 | 200 | 56 | 4 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 200 | 56 | 4 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-04 | 97 | 56 | 3 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.59e-04 | 110 | 56 | 3 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-04 | 125 | 56 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.71e-04 | 129 | 56 | 3 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.84e-04 | 130 | 56 | 3 | 6c6a8b77af08b30b424d4f5def37315d3c6e28b2 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.84e-04 | 130 | 56 | 3 | 0219d0d5d21df08f816569c7eb34f1bfa095d29a | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast-mesenchymal_B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.84e-04 | 130 | 56 | 3 | 0706092f6b466585b3b4808b3b982a122d66cfcf | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-4|TCGA-Uterus / Sample_Type by Project: Shred V9 | 5.97e-04 | 131 | 56 | 3 | 1801611e6b63aa07629e7ccc692f45a7e93c8dd8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.97e-04 | 131 | 56 | 3 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-04 | 132 | 56 | 3 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-04 | 132 | 56 | 3 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 136 | 56 | 3 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | Cerebellum-Macroglia-CSF_related|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 137 | 56 | 3 | f004199b654143e9e766e5c5f56858089e98cf5f | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 137 | 56 | 3 | 6a5599af9d0ee1be6cac17af09aa4cd50774c683 | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 137 | 56 | 3 | ce7c57dad201bd2164fc8b1172aca709f3f7def2 | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 137 | 56 | 3 | 01cbc9082e10ef51a1763a8b2d708eea0434490f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-04 | 137 | 56 | 3 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | Cerebellum-Macroglia-CSF_related-CHOROID_PLEXUS-Choroid_Plexus.Ttr_(Ttr)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 137 | 56 | 3 | a22730b6f78b66bb3c46155af37c34e554672dee | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.10e-04 | 139 | 56 | 3 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| Drug | fast white | 7.02e-16 | 42 | 56 | 9 | CID000024008 | |
| Drug | formycin triphosphate | 4.71e-15 | 51 | 56 | 9 | CID000122274 | |
| Drug | purealin | 1.63e-14 | 58 | 56 | 9 | CID006419303 | |
| Drug | SM-2 | 7.43e-13 | 87 | 56 | 9 | CID000486033 | |
| Drug | clenbuterol | 1.80e-12 | 142 | 56 | 10 | CID000002783 | |
| Drug | S-(-)-Etomoxir | 2.69e-12 | 100 | 56 | 9 | CID000060765 | |
| Drug | carvedilol | 6.35e-12 | 161 | 56 | 10 | CID000002585 | |
| Drug | blebbistatin | 1.05e-11 | 116 | 56 | 9 | CID003476986 | |
| Drug | B0683 | 1.13e-11 | 117 | 56 | 9 | CID006398969 | |
| Drug | oxovanadium | 1.42e-11 | 120 | 56 | 9 | CID000024411 | |
| Drug | 2bq7 | 1.78e-11 | 123 | 56 | 9 | CID006540267 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 MYH7B YME1L1 ADCY3 MUSK | 1.80e-11 | 324 | 56 | 12 | CID000005566 |
| Drug | AC1LADJ6 | 2.94e-11 | 130 | 56 | 9 | CID000486032 | |
| Drug | AC1NRBPQ | 4.73e-11 | 137 | 56 | 9 | CID005288569 | |
| Drug | 4-chloroaniline | 6.03e-11 | 202 | 56 | 10 | CID000007812 | |
| Drug | candesartan cilexetil | 7.88e-11 | 145 | 56 | 9 | CID000002540 | |
| Drug | eye gene | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 MYH7B ADCY3 RBCK1 PLCE1 | 8.08e-11 | 369 | 56 | 12 | CID000004782 |
| Drug | AC1N9ZZC | 1.01e-10 | 149 | 56 | 9 | CID004369374 | |
| Drug | AC1L1IZ2 | 1.75e-10 | 304 | 56 | 11 | CID000004795 | |
| Drug | creatine | 1.01e-09 | 193 | 56 | 9 | CID000000586 | |
| Drug | NSC9700 | CYP1B1 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 MYH7B YME1L1 ADCY3 MUSK | 1.11e-09 | 578 | 56 | 13 | CID000005408 |
| Drug | nocodazole | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 RBBP6 MYH7B CKAP2 GOLGA4 | 1.51e-09 | 477 | 56 | 12 | CID000004122 |
| Drug | verapamil | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 MYH7B YME1L1 ADCY3 MUSK | 2.04e-09 | 490 | 56 | 12 | CID000002520 |
| Drug | N-ethylmaleimide | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 KIF3B MYH13 MYH7B DLD ADCY3 | 3.27e-09 | 511 | 56 | 12 | CID000004362 |
| Drug | NSC339663 | 9.71e-09 | 250 | 56 | 9 | CID000003892 | |
| Drug | MgCl2 | 1.37e-08 | 354 | 56 | 10 | CID000024584 | |
| Drug | NSC107658 | 5.54e-08 | 306 | 56 | 9 | CID000002919 | |
| Drug | nifedipine | 6.12e-08 | 415 | 56 | 10 | CID000004485 | |
| Drug | NSC611747 | 1.82e-07 | 352 | 56 | 9 | CID000002534 | |
| Drug | pyrophosphate | 4.64e-07 | 654 | 56 | 11 | CID000001023 | |
| Drug | isoproterenol | 5.81e-07 | 669 | 56 | 11 | CID000003779 | |
| Drug | D-triiodothyronine | 6.41e-07 | 409 | 56 | 9 | CID000000861 | |
| Drug | carbachol | 7.65e-07 | 688 | 56 | 11 | CID000002551 | |
| Drug | K-Cl | 1.08e-06 | 567 | 56 | 10 | CID000004873 | |
| Drug | 4-epidoxorubicin | CYP1B1 MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 MYH7B YME1L1 | 2.86e-06 | 788 | 56 | 11 | CID000001690 |
| Drug | 8-(methylsulfonyl)FAD | 5.94e-06 | 2 | 56 | 2 | CID000192431 | |
| Drug | Spermine | 1.75e-05 | 63 | 56 | 4 | ctd:D013096 | |
| Drug | NSC226080 | 1.84e-05 | 782 | 56 | 10 | CID000005040 | |
| Drug | AC1NFC6P | 3.17e-05 | 148 | 56 | 5 | CID000004587 | |
| Drug | LY294002 | 8.07e-05 | 748 | 56 | 9 | CID000003973 | |
| Drug | GC 1 compound | 8.86e-05 | 6 | 56 | 2 | ctd:C413355 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.04e-04 | 190 | 56 | 5 | 5586_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.06e-04 | 191 | 56 | 5 | 7379_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.09e-04 | 192 | 56 | 5 | 5509_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 56 | 5 | 3866_UP | |
| Drug | wartmannin | 1.49e-04 | 811 | 56 | 9 | CID000005691 | |
| Drug | AC1NDQQF | 1.98e-04 | 46 | 56 | 3 | CID004630071 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.14e-24 | 10 | 54 | 9 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.50e-23 | 12 | 54 | 9 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.50e-23 | 12 | 54 | 9 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 8.10e-23 | 13 | 54 | 9 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.66e-22 | 15 | 54 | 9 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.48e-18 | 80 | 54 | 11 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.81e-16 | 48 | 54 | 9 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 7.79e-15 | 71 | 54 | 9 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Caveolinopathy | 1.97e-05 | 4 | 54 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.97e-05 | 4 | 54 | 2 | 192600 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.97e-05 | 4 | 54 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.97e-05 | 4 | 54 | 2 | cv:C3495498 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 6.86e-05 | 7 | 54 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 6.86e-05 | 7 | 54 | 2 | C0597124 | |
| Disease | Distal arthrogryposis | 1.17e-04 | 9 | 54 | 2 | cv:C0265213 | |
| Disease | anemia (phenotype), response to ribavirin | 1.17e-04 | 9 | 54 | 2 | EFO_0004272, GO_1901559 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.17e-04 | 9 | 54 | 2 | C0949658 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.47e-04 | 10 | 54 | 2 | cv:C5675009 | |
| Disease | Paroxysmal atrial fibrillation | 1.94e-04 | 156 | 54 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 1.94e-04 | 156 | 54 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.94e-04 | 156 | 54 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 2.13e-04 | 160 | 54 | 4 | C0004238 | |
| Disease | Left ventricular noncompaction | 2.95e-04 | 14 | 54 | 2 | C1960469 | |
| Disease | C-reactive protein measurement | 3.13e-04 | 1206 | 54 | 9 | EFO_0004458 | |
| Disease | cholelithiasis | 5.70e-04 | 88 | 54 | 3 | EFO_0004799 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 7.42e-04 | 22 | 54 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 7.42e-04 | 22 | 54 | 2 | cv:C0949658 | |
| Disease | suntan | 9.00e-04 | 103 | 54 | 3 | EFO_0004279 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 9.60e-04 | 25 | 54 | 2 | C4551472 | |
| Disease | gallstones | 1.03e-03 | 108 | 54 | 3 | EFO_0004210 | |
| Disease | Limb-girdle muscular dystrophy | 1.04e-03 | 26 | 54 | 2 | cv:C0686353 | |
| Disease | phosphatidylcholine 38:4 measurement | 1.21e-03 | 28 | 54 | 2 | EFO_0010386 | |
| Disease | Primary familial dilated cardiomyopathy | 1.38e-03 | 30 | 54 | 2 | cv:C0340427 | |
| Disease | Antihypertensive use measurement | 1.41e-03 | 265 | 54 | 4 | EFO_0009927 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 1.48e-03 | 31 | 54 | 2 | OBA_2045198 | |
| Disease | Heart Failure, Diastolic | 1.67e-03 | 33 | 54 | 2 | C1135196 | |
| Disease | Primary dilated cardiomyopathy | 1.78e-03 | 34 | 54 | 2 | cv:C0007193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELEDMKMKISALKSE | 376 | Q12979 | |
| ASEGMKMEESKLIKA | 306 | Q8WY36 | |
| ECKKEMLDVKFMADT | 196 | Q14254 | |
| MLDVKFMADTKIADS | 201 | Q14254 | |
| EAMGKAEAERMKLKA | 331 | Q14254 | |
| EKIASFSKDAMMKEK | 81 | Q8IYM0 | |
| EMADAAATAKEIKQM | 236 | Q8N3C7 | |
| DKMLAQSKTEKAEEM | 596 | Q8IWG1 | |
| KEAKEMIMSVLDTKS | 116 | Q9H694 | |
| TKMADKENMKRPAES | 76 | Q8WWK9 | |
| FKQDKKGMMIDEADE | 586 | Q5JSJ4 | |
| EKEMASMKEEFTRLK | 846 | P12883 | |
| AEEKAKKAITDAAMM | 1751 | P12883 | |
| KKAITDAAMMAEELK | 1756 | P12883 | |
| GVMKMSAEDIEKVNK | 146 | Q9ULC4 | |
| GVMKMSAEDIEKVNK | 146 | A0A3B3IRV3 | |
| EMEDDKSKMEKKESN | 1501 | Q13439 | |
| KAKEAMKAQMAEKEA | 686 | Q9BQS8 | |
| MDEKTKKAEEMALSL | 1 | Q9BYM8 | |
| VVEFKMEESMKKAAE | 116 | P52272 | |
| CDKTAKAMDEMKNLK | 676 | Q5CZC0 | |
| FKKEKEATMDAVMTR | 131 | Q9UL16 | |
| ESAAKMIKETMDKKF | 51 | O96015 | |
| EEKAKKAITDAAMMA | 1801 | A7E2Y1 | |
| KAITDAAMMAEELKK | 1806 | A7E2Y1 | |
| EKAKKAITDAAMMAE | 1756 | P13535 | |
| AITDAAMMAEELKKE | 1761 | P13535 | |
| MAATMKKAAAEDVNV | 1 | Q9NQP4 | |
| LKSAETEKEMATMKE | 846 | Q9UKX2 | |
| AKKAITDAAMMAEEL | 1761 | Q9UKX2 | |
| AEEKEEAREKMMAAK | 16 | Q9GIP4 | |
| EEKAKKAITDAAMMA | 1756 | P12882 | |
| KAITDAAMMAEELKK | 1761 | P12882 | |
| AEANASEEDKIKAMM | 121 | Q7Z6E9 | |
| LESDDDKMVKKIAMR | 36 | Q92772 | |
| KVAKQMAAEEAMKAL | 666 | P55265 | |
| ELELTKMDKMSFVEK | 2596 | P49454 | |
| KERDAAIMKMAKEAG | 126 | Q49AN0 | |
| VEQMDIDCKKFAKDM | 1306 | Q9UFH2 | |
| AVGETDAKMMKKEAL | 161 | Q5JV73 | |
| HVADEMLKDMKKDES | 286 | O60266 | |
| MLKEKKAMTAEASEL | 691 | O43303 | |
| DKMMEQKSTAVKALT | 121 | P09622 | |
| VKENEMAAKETEKFM | 36 | Q502W7 | |
| DMMDAFILSAEKKAA | 291 | Q16678 | |
| VEEEEKAAEMHKMKS | 81 | P78347 | |
| TDALVAMEKAMKRDK | 271 | Q9Y3I0 | |
| AMKMLEKDVCEKQDA | 376 | Q7L099 | |
| DKEVSLMAEMDKVKE | 266 | Q9NUQ6 | |
| DDEMATRKAKMHKEC | 1101 | Q9P212 | |
| EEKAKKAITDAAMMA | 1756 | Q9Y623 | |
| KAITDAAMMAEELKK | 1761 | Q9Y623 | |
| LKSAETEKEMATMKE | 841 | P11055 | |
| TEKEMATMKEEFQKT | 846 | P11055 | |
| AKKAITDAAMMAEEL | 1756 | P11055 | |
| LLKSAETEKEMATMK | 841 | P13533 | |
| KAKKAITDAAMMAEE | 1756 | P13533 | |
| VAAKMEVKKCVDTMA | 56 | O95968 | |
| AVMTQKMSEKDTKEE | 91 | Q12798 | |
| EKDAAEMLGAKIKAM | 456 | O15066 | |
| EEKAKKAITDAAMMA | 1756 | Q9UKX3 | |
| KAITDAAMMAEELKK | 1761 | Q9UKX3 | |
| EKEMKSLARKAMDTE | 176 | Q9BZW7 | |
| KAAVDGKEMVTMKEL | 556 | Q96TA2 | |
| KMMDIVAAKEAALIK | 1121 | Q15643 | |
| VKDFTMKDIEEKMEA | 161 | H3BQB6 | |
| DKMVTKKSAEGAMDL | 16 | Q15560 | |
| MASDELKEIRKAMTK | 226 | Q15560 | |
| MSDKPDMAEIEKFDK | 1 | P62328 | |
| VAVKMLKEEASADMQ | 606 | O15146 |